Target Price | $139.48 |
Price | $106.57 |
Potential |
30.88%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target BioNTech SE - ADR 2026 .
The average BioNTech SE - ADR target price is $139.48.
This is
30.88%
register free of charge
$181.37
70.19%
register free of charge
$110.68
3.85%
register free of charge
|
|
A rating was issued by 25 analysts: 19 Analysts recommend BioNTech SE - ADR to buy, 6 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BioNTech SE - ADR stock has an average upside potential 2026 of
30.88%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 3.18 | 2.39 |
27.96% | 24.77% | |
EBITDA Margin | -31.29% | -69.24% |
209.49% | 121.29% | |
Net Margin | -24.18% | -55.35% |
199.27% | 128.88% |
17 Analysts have issued a sales forecast BioNTech SE - ADR 2025 . The average BioNTech SE - ADR sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an BioNTech SE - ADR EBITDA forecast 2025. The average BioNTech SE - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 BioNTech SE - ADR Analysts have issued a net profit forecast 2025. The average BioNTech SE - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.20 | -5.51 |
172.23% | 72.19% | |
P/E | negative | |
EV/Sales | 2.57 |
7 Analysts have issued a BioNTech SE - ADR forecast for earnings per share. The average BioNTech SE - ADR EPS is
This results in the following potential growth metrics and future valuations:
BioNTech SE - ADR...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 05 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jun 03 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 29 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 22 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 22 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 14 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 06 2025 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 05 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 03 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 29 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 22 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 22 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 14 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.